TX-MARY-KAY
4.11.2021 13:14:11 CET | Business Wire | Press release
Mary Kay Inc., a leading corporate advocate of women’s empowerment and entrepreneurship, announced today its second World Series of Innovation (WSI) Challenge in partnership with Network for Teaching Entrepreneurship (NFTE). In its second year partnering with NFTE, Mary Kay is sponsoring the 2021 NFTE World Series of Innovation, a global educational experience that invites young people ages 13-24 to channel their critical thinking and problem-solving skills to find solutions for the biggest challenges facing the world today and help advance the UN Sustainable Development Goals (SDGs) while fostering an entrepreneurial mindset.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211104005178/en/
Mary Kay’s World Series of Innovation Challenge encourages young people from around the world to submit innovative solutions to address Sustainable Development Goal 5: Gender Equality . Specifically, this challenge asks students to think about ways to promote workplace equality and ensure equal access to economic opportunity for women and girls. Pre-Covid, decades of data demonstrated the rise of women in the workforce -even though the wage gap persisted - more women were joining the labor market every year. But pandemic job losses disproportionately impacted women, and since 2020, the uphill climb to workforce equality has grown even steeper.
“Mary Kay knows the importance of entrepreneurship and the role it plays in the world today and in the future, which is why we invest annually in programs and initiatives to help empower women and girls around the world,” said Deborah Gibbins, Chief Operating Officer for Mary Kay Inc. “We want to help not only provide educational opportunities but help them pursue their dreams around the world. We are beyond excited for this challenge so connected to our company’s core mission.”
NFTE is a global educational nonprofit focused on bringing the power of entrepreneurship to youth in low-income communities. The World Series of Innovation (WSI) Challenge invites corporate sponsored challenges to address the UN Sustainable Development Goals. With a reach of 100,000 students worldwide, in 2020, NFTE received nearly 4,000 student participants of all backgrounds submitting ideas in the WSI Challenges and nearly 350 students participated in the first-ever Mary Kay-sponsored challenge to address Sustainable Development Goal 12: Responsible Consumption and Production. The three winners of Mary Kay’s 2020 Challenge were:
-
First Place: Loop Tee Loop
- Loop Tee Loop is a sustainable clothing loop uniting lyocell textile mills with uniform recycling collection services from Metro Manila in the Philippines.
-
Second Place: SwagSwap
- SwagSwap is a US-based social network for thrifting, enabling peer-to-peer clothing swap for teens.
-
Third Place: Project DBrand
- Project DBrand is a unique service that de-brands used uniforms so they can be upcycled based in the US.
“Supporting the entrepreneurial development of young people is critical to help build a better world for future generations,” said J.D. LaRock, President and Chief Executive Officer of NFTE. “Each year, we continue to be inspired by the innovations the next generation of entrepreneurs envision, and we look forward to seeing all the new ideas from WSI competitors in 2021. We are grateful to Mary Kay Inc. for its support for the second year posing this critical global challenge to help advance workplace equality and achieve equal access to economic opportunity for women and girls.”
In addition to the World Series of Innovation, Mary Kay supported NFTE’s Entrepreneurship in Every School program, bringing the entrepreneurial journey through curriculum to students across the U.S. and internationally; and sponsored NFTE’s Regional Youth Entrepreneurship Challenges where students pitch business opportunities for seed money in a competitive setting.
The 2021 NFTE World Series of Innovation is presented by Citi Foundation and features challenges from Bank of the West, Citi Foundation, Ernst & Young LLP (EY US), Mary Kay, Inc., Maxar Technologies, PIMCO, and Saint-Gobain. Challenges launched on September 15th and entries are due by December 15th . Judging begins in January of 2022. Finalists will be announced in February and winners will be announced on March 31st .
For more information about the World Series of Innovation and all challenges, visit https://innovation.nfte.com
About Mary Kay
One of the original glass ceiling breakers, Mary Kay Ash founded her beauty company more than 56 years ago with three goals: develop rewarding opportunities for women, offer irresistible products, and make the world a better place. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skin care, color cosmetics and fragrances. Mary Kay is committed to empowering women and their families by partnering with organizations from around the world, focusing on supporting cancer research, protecting survivors from domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Mary Kay Ash’s original vision continues to shine—one lipstick at a time. Learn more about Mary Kay at www.marykayglobal.com
About NFTE
Network for Teaching Entrepreneurship (NFTE) is a global nonprofit organization that provides high-quality entrepreneurship education to middle and high school students from under-resourced communities, as well as programs for college students and adults. NFTE will reach 45,000 students this academic year, with programs in 25 states across the U.S. and in 20 additional countries. Since our founding, we have educated more than a million students through in-school, out-of-school, college, and summer camp programs, offered in person and online. To learn more about how we are promoting inclusive capitalism and building the next generation of diverse entrepreneurs, visit www.nfte.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20211104005178/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
